Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
54
Frequently Asked Questions
What is Market Cap of Seaport Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Seaport Therapeutics Inc. market cap is $1.04B.
What is the 52-week high for Seaport Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Seaport Therapeutics Inc. 52 week high is $23.00 as of May 02, 2026.
What is the 52-week low for Seaport Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Seaport Therapeutics Inc. 52 week low is $18.00 as of May 02, 2026.
What is Seaport Therapeutics Inc. stock price today?
Seaport Therapeutics Inc. stock price today is $19.84.
What was Seaport Therapeutics Inc. stock price yesterday?
Seaport Therapeutics Inc. stock price yesterday was $18.00.
What is the 50-day moving average of Seaport Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Seaport Therapeutics Inc. 50-day moving average is $18.92.
How many employees does Seaport Therapeutics Inc. have?